SCHEMBL9535146

SCHEMBL9535146

CCCc1c(C(F)(F)F)n(CC)c(=O)n1Cc1ccc(-c2ccccc2C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.56
AGTR1 P30556 1/20 0.52
AGTR2 P50052 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9531857 0.95 PPARG (0.57) PPARGAGTR1AGTR2
SCHEMBL9533641 0.94 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL9553889 0.93 PPARG (0.55) PPARGAGTR1AGTR2
SCHEMBL9553974 0.91 PPARG (0.56) PPARGAGTR1AGTR2
SCHEMBL9036413 0.91 AGTR1 (0.59) PPARGAGTR1AGTR2
SCHEMBL9531718 0.91 PPARG (0.53) PPARGAGTR1AGTR2
SCHEMBL9553762 0.91 AGTR1 (0.56) PPARGAGTR1AGTR2
SCHEMBL9555014 0.91 PPARG (0.49) PPARGAGTR1AGTR2
SCHEMBL9531723 0.89 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9531336 0.89 PPARG (0.51) PPARGAGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed